What is Gilead Sciences's total equity?

Gilead Sciences (GILD) reported total equity of $23.52B in Q1 2026.

How has Gilead Sciences's total equity changed year-over-year?

Gilead Sciences's total equity increased by 22.7% year-over-year, from $19.16B to $23.52B.

What is the long-term trend for Gilead Sciences's total equity?

Over 5 years (2020 to 2025), Gilead Sciences's total equity has grown at a 4.5% compound annual growth rate (CAGR), from $18.2B to $22.7B.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Gilead Sciences GILD Total Equity

Total Equity at other companies

Bristol-Myers SquibbBMY

$20.07B+15.4%

IncyteINCY

$5.62B+53.3%

ImmunityBio, Inc.IBRX

-$870.01M-47.1%

PrecigenPGEN

$20.24M+244%

AnaptysBio, Inc.ANAB

$12.75M-62.5%

Iovance Biotherapeutics, Inc.IOVA

$721.75M-6.0%

Other financials

Income statement

See full

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

See full

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total assets$56.3B-0.3%

Cash flow

See full

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

See full

Market cap$162.47B+15.4%

Enterprise value$177.02B+10.2%

P/E17.6×-4.7×

P/S5.5×+0.6×

Profitability

See full

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

See full

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gilead Sciences's total equity?: Gilead Sciences (GILD) reported total equity of $23.52B in Q1 2026.
How has Gilead Sciences's total equity changed year-over-year?: Gilead Sciences's total equity increased by 22.7% year-over-year, from $19.16B to $23.52B.
What is the long-term trend for Gilead Sciences's total equity?: Over 5 years (2020 to 2025), Gilead Sciences's total equity has grown at a 4.5% compound annual growth rate (CAGR), from $18.2B to $22.7B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.